Company profile
Ligand Pharmaceuticals Inc Insider Trading
LGNDEvery SEC Form 4 insider trading filing for Ligand Pharmaceuticals Inc (LGND) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0000886163
- Filings
- 138
- Insiders
- 11
- Last filing
- 2026-08-12
Activity summary
Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares versus 1 sale. Buying was led by Haas Jason.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Ligand Pharmaceuticals Inc insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $15.8M.
90 day insight
Over the last 90 days, Ligand Pharmaceuticals Inc insiders bought $665K (8 transactions) and sold $5.5M (6 transactions).
- Most active insider: Reardon Andrew with 23 transactions totaling $3.6M.
- Largest single sale: $9.2M by Espinoza Octavio on Aug 12, 2026.
- 76% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity is mixed — buys and sales are roughly balanced.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Espinoza Octavio | LGND | Option Exercise10b5 | 16,179 | $52.84 | $855K |
| Aug 12, 2026 | Haas Jason | LGND | Option Exercise | 6,138 | — | — |
| Aug 12, 2026 | Espinoza Octavio | LGND | Option Exercise10b5 | 2,074 | — | — |
| Aug 12, 2026 | Espinoza Octavio | LGND | Option Exercise10b5 | 3,348 | $68.74 | $230K |
| Aug 12, 2026 | Espinoza Octavio | LGND | Option Exercise10b5 | 7,171 | $57.22 | $410K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=LGND" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Ligand Pharmaceuticals Inc as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →